A cautionary tale of a man with haemochromatosis, chronic kidney disease and anaemia referred for erythropoietin therapy

Gareth Lewis; Alexander P. Maxwell

doi:10.1093/ndtplus/sfp168

A cautionary tale of a man with haemochromatosis, chronic kidney disease and anaemia referred for erythropoietin therapy

Research output: Contribution to journal › Article › peer-review

Abstract

Erythropoiesis stimulating agents (ESAs) are used to mange anaemia secondary to chronic kidney disease (CKD). ESAs have also been used to augment the rate of iron loss by phlebotomy in some iron storage disorders. We report the use of erythropoietin to allow enhanced iron removal in a man with both hereditary haemochromatosis and CKD. The patient subsequently presented with more severe anaemia that prompted a search for an underlying occult malignancy. The case history illustrates the importance of considering alternative causes for anaemia in patients with CKD.

Original language	English
Pages (from-to)	145-147
Number of pages	3
Journal	NDT Plus
Volume	3
Issue number	2
DOIs	https://doi.org/10.1093/ndtplus/sfp168
Publication status	Published - 01 Apr 2010
Externally published	Yes

Keywords

colorectal carcinoma
erythropoietin
haemochromatosis

ASJC Scopus subject areas

Nephrology
Transplantation

Access to Document

10.1093/ndtplus/sfp168

Link to publication in Scopus

Fingerprint Dive into the research topics of 'A cautionary tale of a man with haemochromatosis, chronic kidney disease and anaemia referred for erythropoietin therapy'. Together they form a unique fingerprint.

Cite this

@article{858c39b013644f5b881cf2d252a35b48,

title = "A cautionary tale of a man with haemochromatosis, chronic kidney disease and anaemia referred for erythropoietin therapy",

abstract = "Erythropoiesis stimulating agents (ESAs) are used to mange anaemia secondary to chronic kidney disease (CKD). ESAs have also been used to augment the rate of iron loss by phlebotomy in some iron storage disorders. We report the use of erythropoietin to allow enhanced iron removal in a man with both hereditary haemochromatosis and CKD. The patient subsequently presented with more severe anaemia that prompted a search for an underlying occult malignancy. The case history illustrates the importance of considering alternative causes for anaemia in patients with CKD.",

keywords = "colorectal carcinoma, erythropoietin, haemochromatosis",

author = "Gareth Lewis and Maxwell, {Alexander P.}",

year = "2010",

month = apr,

day = "1",

doi = "10.1093/ndtplus/sfp168",

language = "English",

volume = "3",

pages = "145--147",

journal = "Accountancy Plus",

issn = "1753-0784",

publisher = "CPA Ireland",

number = "2",

}

TY - JOUR

T1 - A cautionary tale of a man with haemochromatosis, chronic kidney disease and anaemia referred for erythropoietin therapy

AU - Lewis, Gareth

AU - Maxwell, Alexander P.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Erythropoiesis stimulating agents (ESAs) are used to mange anaemia secondary to chronic kidney disease (CKD). ESAs have also been used to augment the rate of iron loss by phlebotomy in some iron storage disorders. We report the use of erythropoietin to allow enhanced iron removal in a man with both hereditary haemochromatosis and CKD. The patient subsequently presented with more severe anaemia that prompted a search for an underlying occult malignancy. The case history illustrates the importance of considering alternative causes for anaemia in patients with CKD.

AB - Erythropoiesis stimulating agents (ESAs) are used to mange anaemia secondary to chronic kidney disease (CKD). ESAs have also been used to augment the rate of iron loss by phlebotomy in some iron storage disorders. We report the use of erythropoietin to allow enhanced iron removal in a man with both hereditary haemochromatosis and CKD. The patient subsequently presented with more severe anaemia that prompted a search for an underlying occult malignancy. The case history illustrates the importance of considering alternative causes for anaemia in patients with CKD.

KW - colorectal carcinoma

KW - erythropoietin

KW - haemochromatosis

UR - http://www.scopus.com/inward/record.url?scp=77955962005&partnerID=8YFLogxK

U2 - 10.1093/ndtplus/sfp168

DO - 10.1093/ndtplus/sfp168

M3 - Article

AN - SCOPUS:77955962005

VL - 3

SP - 145

EP - 147

JO - Accountancy Plus

JF - Accountancy Plus

SN - 1753-0784

IS - 2

ER -